ARTICLE | Clinical News
ALX-0171: Phase I started
July 15, 2013 7:00 AM UTC
Ablynx began an open-label, German Phase I trial to evaluate single escalating-doses and repeated inhalations of ALX-0171 in about 24 adults with hyper-responsive airways. Ablynx plans to start testin...